Article Text

Download PDFPDF
Aetiology, diagnosis, and management of hypopituitarism in adult life


Hypopituitarism is a complex medical condition associated with increased morbidity and mortality, requires complicated treatment regimens, and necessitates lifelong follow up by the endocrinologist. The causes, clinical features, and the management of hypopituitarism including endocrine replacement therapy are considered in this review article.

  • NFPA, non-functioning pituitary adenoma
  • PRL, prolactin
  • FSH, follicle stimulating hormone
  • LH, luteinising hormone
  • DI, diabetes insipidus
  • GH, growth hormone
  • ACTH, adrenocorticotrophic hormone
  • TSH, thyroid stimulating hormone
  • MPHD, multiple pituitary hormone deficiencies
  • MR, magnetic resonance
  • CSF, cerebrospinal fluid
  • BMD, bone mineral density
  • IGF1, insulin-like growth factor 1
  • GHD, growth hormone deficiency
  • AGHD, adult growth hormone deficiency
  • ITT, insulin tolerance test
  • GHRH, growth hormone releasing hormone
  • GST, glucagon stimulation test
  • HPA, hypothalamic-pituitary-adrenal
  • TRH, thyrotrophin releasing hormone
  • GnRH, gonadotrophin releasing hormone
  • HCG, human chorionic gonadotrophin
  • SMR, standardised mortality ratio
  • HRT, hormone replacement therapy
  • QoL, quality of life
  • HC, hydrocortisone
  • PSA, prostate specific antigen
  • hypopituitarism
  • growth hormone deficiency
  • pituitary hormone replacement therapy
  • endocrine replacement therapy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.